Introduction
The development of lentiviral gene transfer vectors has been a recent advance in the field of gene transfer. Lentiviral vectors are attractive because they have the potential to provide long-term expression due to integration into the host cell DNA while retaining the ability to transduce non-dividing cells. [1] [2] [3] [4] Studies in the brains of rats have established the ability of lentiviral vectors to accomplish these goals. 1, 2 Recent advances in human lentiviral (HIV) vector design have reduced safety concerns regarding inadvertent production of replication competent lentivirus 5, 6 and the application of pseudotyped vector technologies has led to production of vectors with increased titers. 1, 7, 8 Thus, HIV vectors appear to be promising gene transfer vehicles by virtue of their ability to: (1) infect non-dividing cells; (2) be produced in high titer; and (3) mediate persistence of transgene expression for greater than 6 months. 1, 2 However, the airway epithelium remains a formidable target for gene transfer vectors. Not only is the proliferative potential of the well differentiated surface epithelium low, 9 but also the apical membrane lacks entry mechanisms for a variety of gene transfer vectors including enhanced gene transfer efficiency to the nasal epithelium of both mice and rats. SO 2 injury also enhanced HIV vectormediated gene transfer to the tracheas of rodents. These data suggest that SO 2 injury increases access of vector to basal cells and/or the basolateral membrane of airway surface epithelial cells. Quantification of gene transfer efficiency in murine tracheas demonstrated that transduction was more efficient when vector was delivered on the day of exposure (7.0%, n = 4) than when vector was delivered on the day after SO 2 exposure (1.7%, n = 4). Gene Therapy (2000) 7, 568-574.
adenoviruses, [10] [11] [12] liposomes, 13, 14 adeno-associated viruses, 15 and retroviruses. 16, 17 HIV vectors have not been extensively studied in airways. In the only published study to date, HIV vectors pseudotyped with the vesicular stomatitis virus (VSV) glycoprotein (G) efficiently transduced undifferentiated airway epithelia, while failing to transduce the well differentiated pseudostratified columnar epithelium of mature human bronchial xenografts. 18 Given the potential advantages of HIV vectors, we explored the utility of this vector system in airway epithelia. After establishing whether HIV vectors could transduce non-dividing airway cells, we examined the ability of these vectors to transduce polarized epithelia in vitro via application of vector to the apical versus the basolateral surfaces. Subsequently, we tested the ability of HIV vectors to transduce the airways of rodents in vivo using injury models to permit basolateral access of vector to target cells.
Results and discussion
Transduction of non-dividing cells As a first step, we investigated whether VSV-G pseudotyped HIV-based lentiviral vectors (Figure 1 whereas the lower titer MuLV (Ampho) vector transduced only 34% of cells ( Figure 2) . Only rare blue cells were detected in aphidicolin-treated cells infected with MuLV Ampho (0.2%) and MuLV (VSV-G) vectors (0.6%), whereas 95% of aphidicolin-treated cells were transduced with the HIV (VSV-G) lentiviral vector. Thus, all three vectors efficiently transduced dividing cells (no aphidicolin), whereas only the HIV-based lentiviral vector efficiently transduced growth-arrested cells (Figure 2 ).
Transduction of polarized well differentiated airway epithelial cells
The localization of receptors for vector binding and uptake is an important consideration for vectors delivered via the airway lumen. Previous studies have demonstrated a distinct polarity of viral receptor expression on the apical versus the basolateral membranes of polarized epithelia: (1) coxsackie-adenoviral receptors (CAR) are expressed on basolateral domains to a much greater extent than on apical domains of MDCK and human airway epithelial cells; [10] [11] [12] (2) amphotropic receptors are similarly expressed predominantly on apical 19 To test the relevance of these observations to HIV vectors, we investigated the transduction efficiency following apical versus basolateral application of an HIV (VSV-G) vector (Figure 1 ) to polarized, well differentiated airway epithelial cells. An important control for these experiments was the use of the transepithelial resistance as a measure of tight junctional integrity, since tight junctions are responsible for the physical separation of the apical and basolateral domains. As shown in Figure 3a , the transepithelial resistances of these preparations were relatively high. Vector administration to the apical surface produced minimal levels of transgene expression, whereas basolateral application of vector to well differentiated human airway cells yielded levels of transgene expression that were significantly (30-fold) greater than levels achieved with apical application of vector (basolateral 20.8 ± 3.6 mU/mg protein; apical 0.69 ± 0.20 mU/mg protein) as determined by ␤-galactosidase enzyme assay (Figure 3b ; n = 3). In contrast, application of an MuLV (VSV-G) lacZ vector to either the apical or basolateral surfaces of well differentiated airway epithelial cells failed to mediate transgene expression (data not shown), consistent with low rates of airway epithelial cell proliferation (1.9%) in well differentiated cultures. These studies imply that uptake mechanisms for VSV-G pseudotyped HIV vectors into quiescent, well differentiated polarized airway cells are predominantly localized to the basolateral membrane.
Persistence in vitro
One attractive feature of retroviral and lentiviral vectors is the potential for long-term transgene expression. Longterm transgene expression mediated by amphotropic and VSV-G pseudotyped MuLV vectors has been reported in undifferentiated airway cell lines with continuous passage on plastic. 20, 21 CFT1 cells, a human CF tracheal epithelial cell line, retrovirally transduced with wild-type CFTR exhibited partial loss of functional expression when cells in continuous passage were studied func- tionally as polarized preparations at 6 months. 22 Longterm expression of lentivirally transduced genes in airway cells has not been extensively studied. Primary airway cells grown on plastic possess many of the features of pleuripotential cells in the airway including an undifferentiated phenotype, polyclonality, and the ability to mature into a complex epithelium composed of multiple differentiated epithelial cell phenotypes. Because injury techniques typically increase vector access to both the basolateral membrane of lumen-facing columnar cells and the previously unexposed surfaces of airway basal cells, 21 we examined the ability of the lacZ transgene to persist when undifferentiated cells were permitted to develop into differentiated epithelial cell phenotypes.
Figure 3 HIV-based lentiviral transduction of polarized cells. (a) Transepithelial resistances of well differentiated human primary airway epithelial cells at the time of infection with HIV vector applied either to the apical or basolateral surface. (b) Transduction of the same well differentiated primary human airway cells 72 h after infection with vector. Transduction (transgene expression) is expressed as milliunits (mU)
Undifferentiated primary human airway cells grown on plastic were transduced with VSV-G pseudotyped HIV lacZ vectors containing either human cytomegalovirus (CMV) or murine phosphoglycerate kinase (muPGK) internal promoters on culture day 1. Four days later, an aliquot of cells was passaged on to TranswellCol inserts and permitted to grow into a well differentiated ciliated columnar epithelium over 30 days while the remaining aliquot was stained in suspension with Xgal to assess initial levels of transduction. The percentages of cells expressing the transgene 4 days after transduction (day 5) and 30 days after transfer to TranswellCol inserts (day 35) are shown in Table 1 . Primary human airway cells transduced with an HIV (VSV-G) vector with an internal murine PGK promoter exhibited a reduction in the percentage of primary airway cells expressing lacZ (24% of day 5 levels, n = 3 transwells) at 35 days. Persistence of lacZ transgene expression mediated by this vector was less than persistence of transgene expression in airway cells mediated by an HIV vector with an internal CMV promoter (55% of day 5 levels). In comparison, persistence of transgene expression was well maintained in cells transduced with an MuLV (VSV-G) lacZ vector (LTR promoter; 80% of day 5 levels). Histologic sections of these cultures demonstrated that the lacZ transgene was Primary airway cells grown on plastic were infected with vector on culture day 1, then disaggregated and split into two aliquots on day 5. One aliquot was stained in suspension with X-gal and the other plated on to two to three Transwell-Col inserts to permit the cells to develop into a polarized, well differentiated epithelium over 30 days (day 35). The percentage of cells expressing the lacZ transgene at 35 days was determined by analysis of images captured from histologic sections. MuLV, murine leukemia virus; VSV-G; vesicular stomatitis virus glycoprotein pseudotype; LTR, promoter elements of the MuLV long terminal repeat; CMV, human cytomegalovirus; muPGK, murine phosphoglycerate kinase. expressed in basal and columnar cells after the 30 days of growth on permeable substrates (data not shown).
Since similar transduction protocols, cell growth parameters, and retroviral envelope proteins were used, it seems unlikely that differences in cell toxicity and growth rates were responsible for the loss of transgene expression. Rather, these data suggest that cis-acting elements within the vector, ie promoters or other components of the vector backbone, contribute to the duration of in vitro persistence.
In vivo infection of rodent nasal epithelium
No studies of direct in vivo airway HIV lentiviral gene transfer have been published to date. We examined the ability of luminal application of lentiviral vectors pseudotyped with VSV-G to transduce nasal airway epithelium in vivo in the absence of injury. HIV (VSV-G) vectors failed to transduce naive (unmodified or injury-free) well differentiated airway epithelia in vivo following luminal application of vector consistent with the findings in polarized cultures (data not shown). Based on previous experience, 21 we evaluated the effect of oxidant gas (SO 2 )-induced modification of host airway on enhancement of lentiviral gene transfer. Instillation of HIV (VSV-G) vector into the right nostril of SO 2 -exposed 3-week-old mice (n = 6) and rats (n = 4) revealed patchy LacZ expression (Figure 4 ) that was predominantly localized to the respiratory and transitional epithelium along the septum and turbinates (Figure 4a-c) . In general, expression was confined to the nostril to which vector was administered or predominantly to the nostril receiving vector. Occasional staining was also detected in the olfactory epithelium. Expression was significantly greater in rats (66.5 ± 12.4 cells per perimeter) than in mice (6.6 ± 1.6 cells per perimeter, Figure 3d) . No staining was detected in the nasal epithelium of vehicle control rats (n = 3) or mice (n = 6). It should be noted that both the vehicle control and vectortreated SO 2 -exposed rats had significant goblet cell hyperplasia. SO 2 inhalational exposure has been shown to increase tracheal retroviral gene transfer by direct injury manifested as denuding of surface epithelial cells and by increased paracellular permeability of the airway epithelium in the less severely injured regions without frank morphologic damage. 21 Similar mechanisms are likely operative in the nasal airways since SO 2 -induced effects tend to be most pronounced in the more proximal airways. 24 
Intratracheal administration
The double tracheostomy technique was performed for vector delivery to defined regions of the tracheas of anesthetized mice. 11, 21 Similar to the findings in the nasal epithelium, HIV vectors failed to transduce murine tracheal epithelia in the absence of injury (data not shown). Mechanical injury, performed by gently pinching the trachea between the cartilaginous rings with a small pair of forceps, followed by administration of an HIV (VSV-G) lacZ vector resulted in patchy, inefficient gene transfer to the tracheas of mice infected with vector, but not vehicle control tracheas. This result was confirmed in histologic sections ( Figure 5 ).
The SO 2 inhalational injury model was subsequently employed to achieve more uniform tracheal injury and to explore further the feasibility of in vivo HIV vector- 
Photomicrographs of X-gal stained histologic sections showing the septum of vehicle control (b) and vector-transduced rat nasal airways (c). Magnification (× 50). (d) Quantification of LacZ expression in mouse and rat proximal nasal airway. Data are expressed as LacZ(+) cells per perimeter transduced with vector. The epithelial circumference in one nostril (outlined in bold black in panel a) is defined as a perimeter. 23 Vector or vehicle was instilled intranasally 1-2 h after SO 2 inhalation. X-gal staining was performed 96 h following intranasal administration of vector or vehicle. *Significantly different from vehicle control by t test or MannWhitney rank sum test. †

Significantly different from mouse by MannWhitney rank sum test.
mediated gene transfer. In this model system, tracheal airway cell proliferation is optimal 24 h after SO 2 inhalation, whereas no significant airway cell proliferation occurs in the first 12 h after SO 2 inhalation as detected by BrdU incorporation. 21 Vector was instilled into the SO 2 -exposed tracheas of anesthetized 3-week-old mice on the same day of oxidant gas exposure (day 0) versus 24 h later (day 1, Figure 6a ). Quantification of gene transfer efficiency (Figure 6b ) demonstrated that transduction of lacZ was more efficient when vector was instilled on the day of injury when cells were not proliferating (7.0 ± 1.7% cells transduced, n = 4) as compared with vector instillation on the day after injury when cell proliferation peaks (1.7 ± 0.7% cells transduced, n = 4), or vehicle controls (0.1 ± 0.07%, n = 3). The efficiency of transduction on the day of injury when cells were not proliferating also falls within the 6-10% range predicted to correct the Gene Therapy CFTR-mediated chloride transport defect in cystic fibrosis. 25 Significant transduction of rat tracheas was also feasible when vector (3.5 ± 1.3%, n = 3) was delivered on the day of SO 2 injury as compared with vehicle controls (0.04 ± 0.02%).
These data differ from our experience with MuLV vectors 21 where the maximal levels of transduction (6%) were achieved when vector was delivered the day after injury, consistent with the peak of airway proliferation (24 h after injury). Presumably, increased paracellular permeability and access to basolateral cell surfaces and basal cells permissive for vector entry 21 are the mechanisms responsible for the enhancement of HIV (VSV-G) vector-mediated transduction of airway cells detected after SO 2 injury, whereas increased cell proliferation, perhaps complimented by increased access, is the dominant mechanism responsible for enhancing MuLV (VSV-G)-mediated gene transfer. The greater efficiency of transduction mediated by HIV VSV-G vectors in the first few hours after SO 2 inhalation, when rates of airway cell proliferation are minimal, suggests that HIV vectors can transduce non-dividing airway cells in vivo.
The efficiency of transduction achieved with HIV vectors was remarkably similar to, rather than better than, the efficiency of transduction reported for pseudotyped MuLV vectors. 21 Since both the MuLV and HIV vectors use the vesicular stomatitis virus glycoprotein as the ligand for vector entry, similar transduction efficiencies might be the expected result if entry is limiting for gene transfer. Alternatively, the use of the muPGK promoter in the HIV vector, which is generally considered to be a weak promoter, might have led to an underestimate of HIV vector-mediated gene transfer efficiency since expression levels might be lower with this promoter. We attempted to use an HIV vector containing the stronger CMV promoter, however, little or no gene transfer was detected in naive (injury-free) or mechanically injured murine tracheas infected with the CMV promoter construct (data not shown). Therefore, we focused all our efforts on the use of the muPGK promoter in vivo.
We have not examined persistence of HIV vectormediated transgene expression in vivo beyond 5-6 days since our initial goal was first to optimize efficiency. Future studies will be necessary to fully evaluate the potential for long-term expression from lentiviral vectors. These studies will have to take into account that reporter transgenes can induce an immune response limiting the duration of transgene expression. Thus, it may be necessary to use species-specific transgenes or immunodeficient animals to assess in vivo persistence.
In summary, human lentiviral vectors pseudotyped with VSV-G preferentially transduced polarized airway epithelia from the basolateral surface similar to what has been previously reported for other gene transfer vectors. [10] [11] [12] [13] [14] [15] [16] [17] As a result, a method (SO 2 inhalation) that increased access of vector delivered via the lumen to the basal cells and the basolateral membrane was required for successful gene transfer. If clinically effective and safe methods can be developed to increase access of vector to target cells, this approach may offer hope for efficient lentivirus-mediated gene transfer. 
Materials and methods
Cell culture Well differentiated cell cultures of primary normal (non-CF) human bronchial or nasal airway cells were prepared as previously described.
14,21,26 Cells were isolated from surgical specimens by enzymatic digestion, plated on collagen-coated 10-cm plastic dishes at a density of 2 × 10 6 cells per dish, and maintained in hormone-supplemented modified LHC9 medium. 26 On culture day 5-6, cells were harvested by trypsin digestion and plated at a density of 2 × 10 5 cells per 12 mm (0.4 m pore size) Transwell-Col insert (Costar, Cambridge, MA, USA) in a 50:50 mixture of LHC Basal (Biofluids, Rockville, MD, USA) and DMEM-H medium supplemented with growth factors, retinoic acid, and bovine serum albumin as previously described. 14, 21 When cultures attained confluence, medium was gently aspirated from the apical surface creating an air-liquid interface. Cells were maintained in culture for 2-3 weeks and used for experiments only after they had developed a well differentiated phenotype characterized by the presence of cilia on greater than 10% of the cells upon visualization by phase contrast microscopy.
X-gal histochemistry
For in vivo studies, animals were killed by CO 2 asphyxia. Excised tracheas were stained in X-gal solution for 6 h and post-fixed in Omnifix II (Ancon Genetics, St Petersburg, FL, USA). 21 To minimize background staining, the pH of all solutions was adjusted to 8.0 with Tris buffer (20 mm final concentration). The unique architecture of the nasal epithelium required a modification of the X-gal staining technique 23 as follows: animal carcasses were decapitated and the nasal cavity immediately fixed by retrograde perfusion of 2% paraformaldehyde/0.2% glutaraldehyde into the nasal cavity via the tracheal remnant. Following removal of soft tissue and the brain by sharp dissection, heads were immersed in fixative for 2 h at 4°C punctuated by intermittent retrograde flushing of the nasal cavity via the tracheal remnant. The nasal cavity was subsequently stained with X-gal by immersion combined with intermittent retrograde flushing for 6 h at 37°C. Heads were post-fixed in 10% neutral buffered formalin for 24 h, rinsed in tap water, and immersed in 70% ethanol until decalcification (Formical; Decal, Congress, NY, USA) was performed. Standard histological sections were cut and counterstained with nuclear fast red.
␤-Galactosidase enzyme assay Expression of the E. coli ␤-galactosidase (lacZ) transgene in well differentiated primary airway epithelial cells was measured using a chemiluminescent reporter assay kit (Galacto-star, Tropix, Bedford, MA, USA). Samples were prepared by excising the filter on which the cells are attached from the plastic holder using a #11 blade scalpel and immersing the filter containing the cells in 100 l lysis buffer. The filter in lysis buffer was freeze-thawed six times in a 95% ethanol-dry ice bath and the remaining solution pelleted at 3000 g in a microfuge. Supernatant (2-20 l) was mixed with 300 l of reaction buffer containing the Galacto-Star substrate supplied by the manufacturer and incubated for 60-90 min. This reaction mixture was placed in a luminometer, measured for 5 s, and the relative light units per sample recorded. A standard curve was generated with serial dilutions of E. coli ␤-galactosidase enzyme (Sigma Chemical, St Louis, MO, USA). The amount of cellular total protein in the supernatant generated from each sample was measured using the bicinchoninic acid (BCA) method (Pierce, Rockford, IL, USA). Data are expressed as milliunits (mU or units × 10 For quantification of gene transfer efficiency in well differentiated cultures, 10-15 images of randomly selected fields of histologic sections from each polarized culture were captured using a light microscope interfaced to a cooled charge coupled device (CCD) camera (Hamamatsu C5985, Hamamatsu, Japan). The percentage of cells transduced from histologic sections of well differentiated cultures or from intact rodent tracheas was calculated by measuring the area of cells transduced relative to the total area populated by cells dosed with vector using the Metamorph image analysis system (Metamorph; Universal Imaging, West Chester, PA, USA). 14, 21 To determine the percentage of vector-transduced cells in rodent tracheas, en face images of tracheas were captured with a CCD camera interfaced to a dissecting microscope. The percentage of cells transduced was calculated by measuring the area of cells transduced relative to the total area occupied by cells dosed with vector using the Metamorph image analysis system. Once images had been captured, intact tracheas were embedded in paraffin and five longitudinal sections (8 m thick) at 50-100 m levels were taken, mounted on slides, then counterstained with nuclear fast red. Histologic sections Gene Therapy from intact rodent tracheas were used to confirm localization of staining to airway epithelial cells, but were not used to quantify transduction in sections due to the limitations of sampling error.
To quantify in vivo gene transfer efficiency in rodent nasal epithelia, у3 coronal histologic sections were taken through the rodent head just caudad to the incisors. 23 The total number of LacZ-positive cells within the nasal epithelial circumference of a nostril, ie a perimeter (see Figure 4) , was counted in each section by light microscopy.
Vector production
The VSV-G pseudotyped human lentiviral vector (HRmuPGKlacZ) used in this study is depicted in Figure 1 . An internal promoter, the murine phosphoglycerate kinase (muPGK) promoter was used to drive transcription of the E. coli lacZ cDNA. This HIV (VSV-G) lacZ vector was produced with the minimal packaging construct which contains deletions of env, vif, vpu, nef, and vpr. 5 Lentiviral vector preparations were purified and concentrated from the conditioned media of transfected cells by ultracentrifugation as previously described.
1,2 HIV (VSV-G) vector stocks were titered in rat 208F fibroblasts and generally exceeded 1 × 10 9 infectious units (IU)/ml. The VSV-G pseudotyped murine leukemia virusderived lacZ vector HIT-LZ used in this study was produced by transient transfection as previously described. 21 The amphotropic enveloped MuLV-derived lacZ vector LNPOZ was produced from a clonal PA317 producer cell line. 27 
Gene transfer
To assess polarity of infection, well differentiated primary airway cells with transepithelial resistances (R t ) approximately 1000 Ohm-cm 2 (measured using an epithelial ohmmeter, EVOM, World Precision Instruments, Sarasota, FL, USA) were infected with HIV vector applied to either the apical or basolateral surfaces (MOI 30) for 2 h at 37°C. For basolateral infections, transwells were inverted with direct application of vector (100 l) to the basolateral surface of the transwell during the period of vector incubation with cells.
In vivo intranasal instillation: Vector (20 l) was administered drop by drop to the right nostril of anesthetized mice or rats (age 3-4 weeks) using gel loading pipette tips. The nasal epithelia of mice receiving vector or vehicle were either injury-free or injured by oxidant gas exposure 1-2 h immediately before vector delivery. All SO 2 treatments were whole body animal exposures in stainless steel inhalation chambers for 3 h at 500 ppm as previously described. 21 Intratracheal instillation: Vector was delivered to the tracheas of anesthetized mice (age 3-4 weeks) or rats (age 3-4 weeks) using the double tracheostomy technique. 11, 21 Tracheas of anesthetized mice were surgically exposed and a distal tracheotomy performed near the carina for ventilation (breathing) and a proximal tracheotomy performed at the first cartilaginous tracheal ring for vector instillation. 11, 21 The region between the two tracheostomies was filled with vector for a defined period of time until subsequent removal by suctioning. The instilled vector was limited to the region between the two tracheostomies by respiration through the distal tracheostomy, which was confirmed by visualization through a dissecting microscope. All intratracheal instillations of HIV vector or vehicle (buffer) were performed as two sequential 10-15 l aliquots for 1 h each (2 h total duration). This time period was chosen as optimal because time periods longer than this resulted in an unacceptably high mortality. The animals were killed 4-5 days after infection, tracheas removed, and stained with X-gal for histochemical analysis.
Statistical analysis
Where possible, data are presented as the mean ± s.e. A one way ANOVA with a correction for multiple comparisons (Student Neuman Keuls method), t tests, and MannWhitney rank sum tests were used to determine statistical significance (P Ͻ 0.05).
